HSF London's finance team has advised the mandated lead arrangers on their successful acquisition financing for GlaxoSmithKline's $13 billion buyout of Novartis' 36.5% stake in their consumer healthcare joint venture.

The team involved in negotiating the financing was led by partner Will Nevin with the assistance of senior associate Elliot Beard and key associates Oliver Henderson and Ben Robinson.

Will Nevin commented: "This deal is one of the largest in the London market to date this year and shows the continued strength and development of our bank-facing acquisition finance practice".